有投资者向药明康德提问, 请问,DEEPSEEK和CHATGPT等AI大模型对贵公司哪些方面能起到积极的作用?公司回答表示,您好,感谢您对公司的关注。 公司始终致力于自身的能力和规模建设,通过独特的“CRDMO”业务模式,不断降低研发门槛,助力客户提升研发效率,为患者带来更多突破性的治疗方案。AI技术在新药研发领域具有很多运用场景,公司一直持续关注和发展与之相关的技术研发和运用,相关信息的重要性...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.